bh IN BRIEF Dr Martin identifies changes in workplace behaviour that signal anxiety disorders and identifies which symptoms are most difficult to treat. Although most depressed patients never go off the job and many who leave, return to work, some do not. Patients with a high level of anxiety or cognitive impairment, a fundamental […]
Read More
bh IN BRIEF More than 50% of Canadians have a chronic disease or condition. Combining direct medical costs and indirect productivity losses, the total economic burden of chronic illness exceeds $100 billion a year. Dr. Wong-Rieger is an acknowledged Canadian expert on health coaching, and discusses the opportunity to reduce the burden of chronic […]
Read More
bh IN BRIEF Dr. Ernst speaks to the importance of early detection and prevention in dealing with an increasing incidence of skin cancer and melanoma in Canada. He refers to sun behaviour as being a key driver of this trend and notes that skin cancer and melanoma need not be feared if caught and […]
Read More
bh IN BRIEF Dr. Shain is an acknowledged Canadian expert on mental health issues in the workplace, and discusses the legal risks employers face if they do not have "psychologically safe workplaces." All Canadian employers now face this duty, which is outlined in more detail in two significant reports he completed for the Mental Health […]
Read More
bh IN BRIEF Dr. Marla Shapiro speaks to the importance of bone health, and her approach to managing this issue among her patients. Since the condition presents itself without symptoms, timely and accurate diagnosis is difficult, and effective treatment is rarely prescribed or maintained. Proactive management is required. The incidence of fractures related […]
Read More
bh IN BRIEF Dr. Morin co-authored a recent study documenting the economic burden of insomnia that suggests employers are bearing a large chunk of those costs through absence and reduced productivity. Of a $6.6 billion total cost estimate for Quebec alone, insomnia-related productivity losses were calculated as $5.0 billion.Dr. Morin cautions that […]
Read More
bh IN BRIEF Biologics are expensive, but are they worth it? Dr. Lacaille has been at the fore in researching the effects of rheumatoid arthritis (RA) on the workplace. These drugs typically have very positive, quick, and longlasting effects on most of those who take them. That noted, these drugs are not for […]
Read Morebh IN BRIEF The first vaccine for Human Papilloma Virus (HPV) was released a year ago. In coming years, the targeted population will expand to include older women and boys. Federal funding of $300 million will have limited impact. Private drug plans often cover vaccines, and employers will be wrestling with the significant potential […]
Read Morebh IN BRIEF For many years, pharmacists have worked to align their training and skills with the broader health needs of their customers. Diabetes presents many opportunities for pharmacists to help patients manage their health, whether adult or child. Many stores feature diabetes ‘clinic days’ that provide comprehensive education, sometimes including representatives from drug […]
Read Morebh IN BRIEF The City of Toronto is among the best-prepared jurisdictions in Canada for a pandemic, a caution bred from its deadly, expensive, and seriously disruptive exposure to SARS in 2003. That noted, a pandemic has important differences from almost any other public or corporate emergency, and so requires specific attention. Since his […]
Read More